BioVersys
Privately held Swiss biopharmaceutical company.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD192m (Public information from Sep 2024)
Company register number CHE-114.512.761
Basel Basel-City (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|
| Revenues | 4.6m | 4.7m | 4.3m | 4.4m |
| % growth | - | 1 % | (8 %) | 4 % |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
CHF2.5m | Seed | ||
| N/A | N/A | Series A | |
* | N/A | €4.3m | Series B |
€360k | Grant | ||
* | €8.0m | Grant | |
CHF19.0m | Series B | ||
€20.0m | Debt | ||
$4.4m | Grant | ||
* | N/A | $24.9m | Series C |
* | $10.1m Valuation: $125m | Series C | |
* | $13.6m Valuation: $125m | Series C | |
* | $6.0m Valuation: $125m | Late VC | |
| Total Funding | AUD143m | ||
Related Content
Recent News about BioVersys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.